Amount Raised
$35 Million
Round Type
Series B
CambridgeManufacturingBiotechnologyHealthcareHealth CareMedicalTherapeuticsInvestors
Description
Cognito Therapeutics raised a $35 million Series B extension round, bringing the total round to $108 million and its total funding to $128 million. The funding will be used to support the HOPE study for the treatment of Alzheimer’s, as well as the continued expansion and protection of its IP position in gamma frequency therapy. It will also be used to support its Ph2 studies in Multiple Sclerosis and Parkinson’s Disease.
Who else raised in Healthcare and Medical around the same time
Companies in the same sectors as Cognito Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Tenon Medical raised $2.6M (Seed) on February 20, 2024.
- Procyrion raised $58M (Series E) on February 5, 2024.
- ViaLase raised $45M (Seed) on January 5, 2024.
- Allurion Technologies raised $123K (Pre-Seed) on December 18, 2023.
- Tessera Defense & Homeland Security Inc. raised $62M on March 15, 2024.
- MAIA Biotechnology raised $2.9M (Seed) on March 11, 2024.
Who to call at Cognito Therapeutics, and when
A new round usually means Cognito Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cognito Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cognito Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cognito Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cognito Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCognito Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.